Skip to main content
search

Market Access & Commercial

Sign up

Latest resources

Featured resource

Latest market access & commercial blogs

Meet our experts at the following events

Conference

2025 ISPE Annual Meeting

August 22 - 26, 2025 – Washington, DC – Booth 303
Conference

BioTechX US 2025

September 16 - 17, 2025 – Philadelphia, PA – Booth #604
Conference

ACoP 2025

October 18 - 21, 2025

All market access & commercial resources

Top 5 Recommendations for Successful Interactive Value Messaging

Certara Products - BaseCase, Blog

Blueprint for Biotech Success: De-risking Early Development to Secure Long-Term Value

Certara Services, Drug Development, Model Informed Drug Development, Webinar

BioTechX US 2025

Certara Products - BaseCase, Certara Products - Simcyp, Certara Services, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - QSP, Conference

Machine Learning (ML) in healthcare

Certara Services, Drug Development, Blog

Model-Based Meta-Analysis (MBMA) at GSK: Real-World Impact on Strategy and Trials

Certara Products, Certara Services, Drug Development, Model Informed Drug Development, Model-Based Meta-Analysis (MBMA), Modeling and Simulation, Therapeutic Specialties, Blog

Optimizing Dosing and Regulatory Outcomes in Duchenne Muscular Dystrophy (DMD) Drug Development

Certara Services, Clinical Pharmacology, Drug Development, Model Informed Drug Development, Modeling and Simulation, Case Study

Maintain & Adapt Pharma Market Access Digital Tools Using Feedback

Certara Products, Certara Products - BaseCase, Value Communication, Blog

Critical Roles for Modeling and Simulation and Real-World Evidence to Inform Challenges in Clinical Trial Diversity Planning

Certara Services, Clinical Trials, Drug Development, Drug Safety, Model Informed Drug Development, Modeling and Simulation, Therapeutic Specialties, Publication

How a budget-impact analysis complements cost-effectiveness to present a balanced economic outlook

Certara Services, HEOR, Blog

What’s next for Trump’s ‘most favored nation’ policy?

Certara Services, Press Coverage

‘Most Favored Nation’ Policy Could Have Profound Impact on Global Drug Pricing if Fully Implemented

Certara Services, Market Access, Blog

Essentials of Model-informed Drug Development in Oncology

Certara Products - Simcyp, Modeling and Simulation - PBPK, Pharmacometrics, Quantitive Systems Pharmacology (QSP), Blog
Sign up to newsletter

Why sign up? Because transforming drug development is not just our goal—it’s our obsession. If it’s yours too, then be the first to know of new insights and join us in pushing the boundaries of science.